Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Thursday, September 4, 2025 12:00 AM

Conditions: Small-cell Lung Cancer; Small Cell Lung Carcinoma; Small Cell Lung Cancer Interventions: Drug: Cirtuvivint; Drug: Irinotecan Sponsors: Washington University School of Medicine; Biosplice Therapeutics, Inc. Not yet recruiting

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

Thursday, August 28, 2025 12:00 AM

Conditions: Lung Cancer; Cancer of the Lung Interventions: Other: Pink and Pearl Campaign Sponsors: Washington University School of Medicine Not yet recruiting

The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal

Tuesday, August 26, 2025 12:00 AM

Conditions: Surgical Wound Infection Interventions: Drug: Chlorhexidine gluconate (4%); Drug: Mupirocin 2% Ointment Sponsors: The Cooper Health System; University of California, Davis; Washington University School of Medicine; Baylor College ...

Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives

Thursday, September 4, 2025 12:00 AM

Conditions: Obstructive Sleep Apnea Interventions: Device: MAD; Device: HGNS Sponsors: Washington University School of Medicine Not yet recruiting

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

Thursday, August 28, 2025 12:00 AM

Conditions: HIV/AIDS; Sexually Transmitted Diseases Interventions: Behavioral: Activities; Behavioral: Benefits; Behavioral: Capacity; Behavioral: Activities-S; Behavioral: Benefits-S; Behavioral: Capacity-S; Behavioral: People; Behavioral: ...

Compass 3: A Novel Transition Program to Reduce Disability After Stroke

Tuesday, September 2, 2025 12:00 AM

Conditions: Stroke Interventions: Behavioral: COMPASS; Behavioral: Education Program Sponsors: Washington University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not yet recruiting

Implement and Test Visual Consent Template and Process

Tuesday, August 26, 2025 12:00 AM

Conditions: Cancer; Alzheimer Disease Interventions: Other: Visual consent; Other: Standard consent Sponsors: Washington University School of Medicine; Agency for Healthcare Research and Quality (AHRQ) Recruiting

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Friday, August 29, 2025 12:00 AM

Conditions: Uterine Cancer; Endometrial Cancer Interventions: Drug: Zanzalintinib; Drug: Paclitaxel Sponsors: Washington University School of Medicine; National Cancer Institute (NCI); Exelixis Not yet recruiting